Agilent Technologies Inc  

(Public, NYSE:A)   Watch this stock  
Find more results for A
47.51
+0.25 (0.53%)
After Hours: 47.43 -0.08 (-0.16%)
Jul 28, 4:49PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 47.02 - 47.75
52 week 33.12 - 47.75
Open 47.19
Vol / Avg. 0.00/2.19M
Mkt cap 15.57B
P/E 34.07
Div/yield 0.12/0.97
EPS 1.39
Shares 325.00M
Beta 1.50
Inst. own 87%
Aug 17, 2016
Q3 2016 Agilent Technologies Inc Earnings Call - 4:30PM EDT - Add to calendar
Aug 17, 2016
Q3 2016 Agilent Technologies Inc Earnings Release - 4:00PM EDT - Add to calendar
Jun 9, 2016
Agilent Technologies Inc at Jefferies Healthcare Conference
Jun 7, 2016
Agilent Technologies Inc at Goldman Sachs Global Healthcare Conference
May 25, 2016
Agilent Technologies Inc Analyst and Investor Meeting - Webcast
May 16, 2016
Q2 2016 Agilent Technologies Inc Earnings Call - Webcast
May 16, 2016
Q2 2016 Agilent Technologies Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '16) 2015
Net profit margin 8.93% 10.85%
Operating margin 12.86% 12.93%
EBITD margin - 21.59%
Return on average assets 4.89% 4.79%
Return on average equity 8.89% 9.25%
Employees 12,200 -
CDP Score - 89 C

Address

5301 Stevens Creek Blvd
SANTA CLARA, CA 95051-7201
United States - Map
+1-408-3458886 (Phone)
+1-408-3458474 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.

Officers and directors

Michael R. McMullen President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Didier Hirsch Chief Financial Officer, Senior Vice President
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael Tang Senior Vice President, General Counsel, Secretary
Bio & Compensation  - Reuters
Dominique P. Grau Senior Vice President - Human Resources
Age: 56
Bio & Compensation  - Reuters
Henrik Ancher-Jensen Senior Vice President, President - Order Fulfillment
Age: 50
Bio & Compensation  - Reuters
Mark Doak Senior Vice President, President - Agilent CrossLab Group
Age: 60
Bio & Compensation  - Reuters
Patrick K. Kaltenbach Senior Vice President, President - Life Sciences and Applied Markets Group
Age: 52
Bio & Compensation  - Reuters
Jacob Thaysen Senior Vice President, President - Diagnostics and Genomics Group
Age: 40
Bio & Compensation  - Reuters
Rodney Gonsalves Principal Accounting Officer, Vice President, Corporate Controller
Age: 50
Bio & Compensation  - Reuters
James G. Cullen Independent Non-Executive Chairman of the Board
Age: 73
Bio & Compensation  - Reuters